SOX2 has increased expression and promotes tumorigenesis in lung, breast, ovarian, and prostate cancers,6,7,9–14,17–19 and is required for CSCs and tumorigenesis in NSCLC.8 This evidence concerns the gene SOX2 and non-small cell lung carcinoma.